The startup using AI to help rare disease families develop custom treatments
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.